BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36443754)

  • 21. Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway.
    Yang TW; Lee WH; Tu SJ; Huang WC; Chen HM; Sun TH; Tsai MC; Wang CC; Chen HY; Huang CC; Shiu BH; Yang TL; Huang HT; Chou YP; Chou CH; Huang YR; Sun YR; Liang C; Lin FM; Ho SY; Chen WL; Yang SF; Ueng KC; Huang HD; Huang CN; Jong YJ; Lin CC
    Sci Rep; 2019 Jul; 9(1):10923. PubMed ID: 31358825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer.
    Zhang H; Jin K; Xiong K; Jing W; Pang Z; Feng M; Cheng X
    Cancer Med; 2023 Jul; 12(14):15720-15735. PubMed ID: 37260140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
    Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
    Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
    Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
    Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
    Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis.
    Liu W; Zhang X; Xu H; Li S; Lau HC; Chen Q; Zhang B; Zhao L; Chen H; Sung JJ; Yu J
    Gastroenterology; 2021 Jun; 160(7):2395-2408. PubMed ID: 33581124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea.
    Kim M; Lee ST; Choi S; Lee H; Kwon SS; Byun JH; Kim YA; Rhee KJ; Choi JR; Kim TI; Lee K
    Sci Rep; 2020 Nov; 10(1):19915. PubMed ID: 33199749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
    Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
    BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
    Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-associated fecal microbial markers in colorectal cancer detection.
    Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
    Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
    Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
    Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature construction.
    Liu J; Huang X; Chen C; Wang Z; Huang Z; Qin M; He F; Tang B; Long C; Hu H; Pan S; Wu J; Tang W
    J Transl Med; 2023 Jun; 21(1):373. PubMed ID: 37291572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences.
    Tortora SC; Bodiwala VM; Quinn A; Martello LA; Vignesh S
    World J Gastrointest Oncol; 2022 Feb; 14(2):375-395. PubMed ID: 35317317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
    Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary and fecal microbiota: potential new biomarkers for early screening of colorectal polyps.
    Zhang L; Feng Z; Li Y; Lv C; Li C; Hu Y; Fu M; Song L
    Front Microbiol; 2023; 14():1182346. PubMed ID: 37655344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Traditional Chinese Medicine Syndrome Type, Gut Microbiome, and Host Immunity in Predicting Early and Advanced Stage Colorectal Cancer.
    Yan Y; Yang Y; Ning C; Wu N; Yan S; Sun L
    Integr Cancer Ther; 2023; 22():15347354221144051. PubMed ID: 36604798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant and Conflicting Correlation of IL-9 With
    Niccolai E; Russo E; Baldi S; Ricci F; Nannini G; Pedone M; Stingo FC; Taddei A; Ringressi MN; Bechi P; Mengoni A; Fani R; Bacci G; Fagorzi C; Chiellini C; Prisco D; Ramazzotti M; Amedei A
    Front Immunol; 2020; 11():573158. PubMed ID: 33488574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metagenomics analysis reveals universal signatures of the intestinal microbiota in colorectal cancer, regardless of regional differences.
    Berbert L; Santos A; Magro DO; Guadagnini D; Assalin HB; Lourenço LH; Martinez CAR; Saad MJA; Coy CSR
    Braz J Med Biol Res; 2022; 55():e11832. PubMed ID: 35293551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
    Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
    Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.